SANTA CLARA, Calif.--(BUSINESS WIRE)--Sept. 8, 2006--Affymetrix Inc. (Nasdaq:AFFX) announced today the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector laboratories. Affymetrix and other microarray and reagent manufacturers participated in the two-year initiative designed to address the reproducibility of data generated from microarrays.
